克罗恩病合并肠系膜纤维瘤病一例  

A case of Crohn′s disease with mesenteric fibromatosis

作　　者：刘益娟 张琳[2] 许烨 张琳琳 李文清[1] 王密[3] 郑贤应[4] 王承党[1] Liu Yijuan;Zhang Lin;Xu Ye;Zhang Linlin;Li Wenqing;Wang Mi;Zheng Xianying;Wang Chengdang(Department of Gastroenterology,The First Affiliated Hospital,Fujian Medical University,The First Clinical Medical College,Fujian Medical University,Fuzhou 350002,China;Department of Gastrointestinal Surgery,The First Affiliated Hospital,Fujian Medical University,Fuzhou 350002,China;Department of Pathology,The First Affiliated Hospital of Fujian Medical University,Fuzhou 350002,China;Department of Radiology,The First Affiliated Hospital,Fujian Medical University,Fuzhou 350002,China)

机构地区：[1]福建医科大学附属第一医院消化内科,福建医科大学第一临床医学院,福州350002 [2]福建医科大学附属第一医院胃肠外科,福州350002 [3]福建医科大学附属第一医院病理科,福州350002 [4]福建医科大学附属第一医院影像科,福州350002

出　　处：《中华炎性肠病杂志（中英文）》2021年第2期191-192,共2页Chinese Journal of Inflammatory Bowel Diseases

基　　金：福建省卫计委创新课题(2018-CX-32)。

摘　　要：克罗恩病合并肠系膜纤维瘤病在临床中少见,我们报道1例克罗恩病患者在英夫利西单克隆抗体治疗1.5年后,合并肠系膜纤维瘤病,有助于提高临床医生的诊治经验。Crohn′s disease complicated with mesenteric fibromatosis is rare in clinical practice.We report a case that the patient with Crohn′s disease developed mesenteric fibromatosis after 1.5 years of infliximab treatment,hoping to enrich clinicians′experience.

关 键 词：克罗恩病 肠系膜纤维瘤病 英夫利西单克隆抗体 甲氨蝶呤 

分 类 号：R735.4[医药卫生—肿瘤] R574.62[医药卫生—临床医学]